Children aged 12-17 years will now be allowed to receive two Pfizer-BioNTech doses in Bahrain
TDT | Manama
The Daily Tribune – www.newsofbahrain.com
Adolescents belonging to the age group 12-17 years will now be allowed to receive the Pfizer-BioNTech vaccine in two doses to protect them from the coronavirus (COVID-19).
The decision was made yesterday after the Health Ministry’s Vaccination Committee members studied all the recommendations issued by the World Health Organization’s Strategic Advisory Group of Experts on Immunization, and the United States Centers for Disease Control to ensure adolescents strengthen their immunity against the virus.
The National Medical Taskforce for Combatting the Coronavirus (COVID-19) noted that the opening of the vaccination registration for adolescents on healthalert.gov.bh will be announced soon.
It added that approval from a guardian is needed when visiting the health centres, in addition to the presence of a guardian when taking the vaccine.
The task force also announced the opening of registration for a booster COVID-19 vaccine dose for the most vulnerable groups in Bahrain, at least six months after taking the second dose of the Sinopharm vaccine, for first responders, as well as citizens and residents above the age of 50, and those suffering from obesity, low immunity, or other underlying health conditions.
Registration for the booster dose will be available through the Health Ministry’s website, healthalert.gov.bh, by clicking on “Register for booster doses” within the registration option.
The task force affirmed its commitment to further develop the Kingdom’s vaccination campaign in accordance with international medical protocols.
Providing booster shots is part of the proactive steps taken by Bahrain in efforts to combat COVID-19 and contribute to safeguarding the health of the community
Related Posts